http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201932604-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d607d32ce3da33038adbbb3a2ab61da9 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08 |
| filingDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6feb7ac864c8d8f994059e3a57ec5ef1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397f8f3bd99ad5617700f4b69501ba26 |
| publicationDate | 2019-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201932604-A |
| titleOfInvention | Preparation method, product and application of human anti-enteric virus type 71 monoclonal antibody |
| abstract | The invention relates to a method, product and application of human-derived anti-enterovirus 71 monoclonal antibody, and to obtain specific enterovirus 71 specificity caused by infection by obtaining peripheral blood of human patients infected with enterovirus 71 natural infection. Human immunoglobulin G secretes B cells, then selects B cell immunoglobulin G variant region genes, and transfects them into human cell lines for expression, thereby obtaining human-derived anti-enterovirus 71 monoclonal antibodies. Anti-enterovirus 71 monoclonal antibodies can specifically and potently neutralize multiple enterovirus 71 subtypes, especially those enterovirus 71 subtypes B4, C4, and B5 that have prevailed in Taiwan and China in recent years. |
| priorityDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.